A novel CXCR4 antagonist derived from human SDF-1β enhances angiogenesis in ischaemic mice | Zendy

Yi Tan | Zendy; Yan Li | Zendy; Jian Xiao | Zendy; Hongwei Shao | Zendy; Chuanlin Ding | Zendy; Gavin E. Arteel | Zendy; Keith A. Webster | Zendy; Jun Yan | Zendy; Hong Yu | Zendy; Lu Cai | Zendy; Xiaokun Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A novel CXCR4 antagonist derived from human SDF-1β enhances angiogenesis in ischaemic mice

Author(s) -

Yi Tan,

Yan Li,

Jian Xiao,

Hongwei Shao,

Chuanlin Ding,

Gavin E. Arteel,

Keith A. Webster,

Jun Yan,

Hong Yu,

Lu Cai,

Xiaokun Li

Publication year - 2009

Publication title -

cardiovascular research

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.774

H-Index - 219

eISSN - 1755-3245

pISSN - 0008-6363

DOI - 10.1093/cvr/cvp044

Subject(s) - angiogenesis , stromal cell derived factor 1 , cxc chemokine receptors , antagonist , cxcr4 antagonist , stromal cell , ischemia , cxcr4 , receptor antagonist , arteriogenesis , medicine , pharmacology , receptor , endocrinology , biology , chemokine , chemokine receptor , chemistry

The effects on angiogenesis of a novel CXC chemokine receptor 4 (CXCR4) antagonist, SDF-1betaP2G, derived from human stromal cell-derived factor-1beta (SDF-1beta), were examined in a model of hind limb ischaemia in mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research